siponimod
siponimod is listed in the FDA National Drug Code directory with 10 NDC codes, marketed under brand name including MAYZENT. Available dosage forms: tablet, film coated, powder.
Drug Details
- Generic Name
- siponimod
- Brand Names
- MAYZENT
- Application Number
- NDA209884
- Sponsor
- Novartis Pharma Stein AG
- NDC Codes
- 10
- Dosage Forms
- TABLET, FILM COATED, POWDER
- Routes
- ORAL
- Active Ingredients
- SIPONIMOD
Indications and Usage
1 INDICATIONS AND USAGE MAYZENT is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. MAYZENT is a sphingosine 1-phosphate (S1P) receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.